이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Repare Therapeutics 미래 성장
Future 기준 확인 1/6
Repare Therapeutics 의 수익은 연간 22.7% 감소할 것으로 예상되는 반면, 연간 수익은 5.3% 로 증가할 것으로 예상됩니다. 5.3% 연간. EPS는 연간 15.3% 만큼 쇠퇴할 것으로 예상됩니다. 자기자본이익률은 3년 후 -69.7% 로 예상됩니다.
주요 정보
-20.1%
수익 성장률
-12.4%
EPS 성장률
| Biotechs 수익 성장 | 28.5% |
| 매출 성장률 | 12.2% |
| 향후 자기자본 수익률 | -56.9% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 23 Sep 2024 |
최근 미래 성장 업데이트
Recent updates
Repare: Q4 2024 Is A Major Inflection Point With Lunresertib, Camonsertib Data
Aug 30Will Repare Therapeutics (NASDAQ:RPTX) Spend Its Cash Wisely?
Jul 12
Repare Therapeutics Inc.'s (NASDAQ:RPTX) 34% Dip In Price Shows Sentiment Is Matching Revenues
May 01Benign Growth For Repare Therapeutics Inc. (NASDAQ:RPTX) Underpins Stock's 30% Plummet
Mar 12We Think Repare Therapeutics (NASDAQ:RPTX) Needs To Drive Business Growth Carefully
Feb 15Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Fly 30% But Investors Aren't Buying For Growth
Dec 20Here's Why We're Not At All Concerned With Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation
Oct 24New Forecasts: Here's What Analysts Think The Future Holds For Repare Therapeutics Inc. (NASDAQ:RPTX)
Aug 14Analysts Are Betting On Repare Therapeutics Inc. (NASDAQ:RPTX) With A Big Upgrade This Week
May 14Analysts Are Upgrading Repare Therapeutics Inc. (NASDAQ:RPTX) After Its Latest Results
May 12Repare Therapeutics Inc. (NASDAQ:RPTX) Looks Inexpensive But Perhaps Not Attractive Enough
May 08Growth Investors: Industry Analysts Just Upgraded Their Repare Therapeutics Inc. (NASDAQ:RPTX) Revenue Forecasts By 31%
Mar 03Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth
Oct 27Repare Therapeutics: Budding Synthetic Lethality Player With 3 Big Pharma Partners
Sep 07Repare Therapeutics GAAP EPS of -$0.91 misses by $0.06, revenue of $0.67M
Aug 04Repare Therapeutics: Interesting Gene Editing Company, But Miles To Go
Jun 27Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth
Jun 24Repare Therapeutics (NASDAQ:RPTX) Is In A Good Position To Deliver On Growth Plans
Mar 02We're Not Worried About Repare Therapeutics' (NASDAQ:RPTX) Cash Burn
Oct 14We Think Repare Therapeutics (NASDAQ:RPTX) Can Easily Afford To Drive Business Growth
Apr 16Have Repare Therapeutics Inc. (NASDAQ:RPTX) Insiders Been Selling Their Stock?
Mar 12Are Institutions Heavily Invested In Repare Therapeutics Inc.'s (NASDAQ:RPTX) Shares?
Feb 08
Repare Therapeutics: CRISPR-Enabled Technology Might Unlock New Therapies
Dec 28Trade Alert: The Executive VP & Head of Business & Corporate Development Of Repare Therapeutics Inc. (NASDAQ:RPTX), Kim Seth, Has Sold Some Shares Recently
Dec 21We Think Repare Therapeutics (NASDAQ:RPTX) Can Easily Afford To Drive Business Growth
Nov 19수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 40 | -152 | -130 | -125 | 6 |
| 12/31/2025 | 11 | -162 | -118 | -117 | 8 |
| 12/31/2024 | 59 | -97 | -63 | -62 | 9 |
| 6/30/2024 | 69 | -69 | -80 | -80 | N/A |
| 3/31/2024 | 98 | -46 | -85 | -83 | N/A |
| 12/31/2023 | 51 | -94 | -129 | -127 | N/A |
| 9/30/2023 | 56 | -97 | -128 | -129 | N/A |
| 6/30/2023 | 167 | -3 | -8 | -8 | N/A |
| 3/31/2023 | 137 | -29 | -2 | -1 | N/A |
| 12/31/2022 | 132 | -29 | 0 | 0 | N/A |
| 9/30/2022 | 121 | -26 | 7 | 9 | N/A |
| 6/30/2022 | 8 | -132 | -114 | -112 | N/A |
| 3/31/2022 | 8 | -120 | -103 | -102 | N/A |
| 12/31/2021 | 8 | -107 | -87 | -86 | N/A |
| 9/30/2021 | 1 | -94 | -81 | -78 | N/A |
| 6/30/2021 | 1 | -77 | -69 | -65 | N/A |
| 3/31/2021 | 0 | -62 | -14 | -11 | N/A |
| 12/31/2020 | 0 | -53 | -8 | -6 | N/A |
| 9/30/2020 | N/A | -46 | -4 | -2 | N/A |
| 6/30/2020 | N/A | -40 | 11 | 12 | N/A |
| 3/31/2020 | N/A | -35 | -32 | -31 | N/A |
| 12/31/2019 | N/A | -27 | -20 | -18 | N/A |
| 12/31/2018 | N/A | -14 | -13 | -13 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: RPTX 향후 3년 동안 수익성이 없을 것으로 예상됩니다.
수익 vs 시장: RPTX 향후 3년 동안 수익성이 없을 것으로 예상됩니다.
고성장 수익: RPTX 향후 3년 동안 수익성이 없을 것으로 예상됩니다.
수익 대 시장: RPTX 의 수익(연간 15.2% ) US 시장( 8.5% 보다 빠르게 성장할 것으로 예상됩니다. 8.5% 연간).
고성장 수익: RPTX 의 수익(연간 5.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: RPTX (는) 3년 내에 수익성이 없을 것으로 예상됩니다.